Lindbrook Capital’s Axogen AXGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$2K Buy
108
+44
+69% +$794 ﹤0.01% 2286
2024
Q4
$1.05K Hold
64
﹤0.01% 2471
2024
Q3
$897 Hold
64
﹤0.01% 2526
2024
Q2
$463 Buy
+64
New +$437 ﹤0.01% 2619
2023
Q2
Sell
-156
Closed -$1.47K 2721
2023
Q1
$1.47K Buy
156
+130
+500% +$1.19K ﹤0.01% 2359
2022
Q4
$259 Sell
26
-141
-84% -$1.57K ﹤0.01% 2697
2022
Q3
$2K Sell
167
-29
-15% -$290 ﹤0.01% 1989
2022
Q2
$2K Buy
+196
New +$1.68K ﹤0.01% 1907

Other funds holding AXGN

Lindbrook Capital's AXGN Position: Q1 2025 in Review

Lindbrook Capital increased its Axogen (AXGN) stake by 69% in Q1 2025, buying an estimated $794 and bringing the position to 108 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #2286.

Lindbrook Capital first reported a position in AXGN in Q2 2022 and has held it in 8 quarters since. The position peaked at $2K in Q3 2022. 181 funds tracked by Wall St. Rank hold AXGN as of Q1 2025.

  • Lindbrook Capital held 108 shares of Axogen worth $2K as of Q1 2025.
  • Lindbrook Capital bought 44 Axogen shares in Q1 2025, an estimated $794.
  • Axogen made up ﹤0.01% of Lindbrook Capital's portfolio in Q1 2025, its #2286 holding.
  • Lindbrook Capital first reported a position in Axogen in Q2 2022 and has held it in 8 quarters since.
  • Lindbrook Capital's Axogen position peaked at $2K in Q3 2022.
  • 181 funds tracked by Wall St. Rank held Axogen as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.